is bpc 157 banned in the us FDA's Overreach on Compounded Peptides bpc-157 current status fda approval

Pharmaceutical Sciences: Dual-peptide intranasal formulations present distinct physicochemical and stability considerations

Populations who should not use BPC-157: Pregnant or breastfeeding individuals (no safety data), anyone with a history of cancer (theoretical concern given pro-angiogenic mechanisms), individuals taking anticoagulants (some animal data suggest effects on platelet aggregation pathways), and anyone without access to sterile technique for injection preparation

When in doubt, its crucial to follow medical advice and not to use sermorelin in scenarios for which it is not intended

For example, animal studies show mast cells in the colon release prostaglandin E2, causing pain and hypersensitivity in IBS (irritable bowel syndrome)